Sr. Director, Assays & Platform Technologies

cellsignalingtechnology79; Danvers (MA); On-site; USD 200,000 - 320,000; Full time

Job summary

Cell Signaling Technology in Danvers, MA is seeking a Sr. Director for Assay and Platform Technologies to define and execute the immunoassay platform strategy, oversee four sub-teams, and drive portfolio leadership from concept to commercial success.

You will lead cross-functional collaborations across R&D, product development, and commercial teams, shaping platform roadmaps, governance, and resource decisions while advancing biotech and pharma workflows.

Job description

Who We Are:

Cell Signaling Technology (CST) is a different kind of life sciences company, one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor for over 20 years. We consistently provide fellow scientists around the globe with best-in-class products and services to fuel their quests for discovery.

Helping researchers find new solutions is our main mission every day, but it's not our only mission. We're also dedicated to helping identify solutions to other problems facing our world. We believe that all businesses must be responsible and work in partnership with local communities, while seeking to minimize their environmental impact. That's why we joined 1% for the Planet as its first life science member, and have committed to achieving net-zero emissions by 2029.

The Role:

As the Sr. Director for Assay and Platform Technologies, you will define and execute the company's collective immunoassay platform strategy, and support critical commercial and business development partnerships. Operating at the intersection of research, product development, and commercial execution, you will oversee portfolio leadership, guide cross-functional collaborations, and lead four immunoassay platform sub-teams to drive innovation from concept through commercial success.

Platform Strategy & Portfolio Leadership (35%)

• Responsible for strategic and operational objectives, work plans, budgets, and portfolio health metrics across the four sub-teams
• Responsible for the development of innovative products and solutions configured for use in established and emerging immunoassay platforms.
• Develop and implement the product development platform strategy across traditional and emerging immunoassays, single-cell analysis, spatial biology, and mass spectrometry-based proteomics; translate CST's strategy into platform-specific roadmaps.
• Product pipeline governance: accountable for the integrity and strategic coherence of the immunoassays product portfolio.
• Responsible for go/no-go recommendations on platform onboarding and resource allocation decisions.
• Collaborates with product development groups (antibody & protein technologies, antibody discovery, application & validation groups, and the Custom Solutions team on strategic and operational objectives, work plans, and portfolio health metrics.
• Resource and budget management: makes decisions on resourcing trade-offs across sub-teams and between R&D platform development and pre/post-sales scientific support activities.
• Drives adoption of new assays and platforms to support pre/post-sales, publishing, and customer engagement in alignment with company's R&D objectives, with priority focus in biotech, pharma, and CRO customer segments.

Scientific Research & Translational Leadership (25%)

• Maintains deep scientific expertise across priority immunoassay platform areas.
• Responsible for the conceptualization or design of products designed to meet the specific needs of biotech, pharma, and CRO customer workflows in drug discovery, biomarker development, and clinical/translational research.
• Informs platform development priorities through active engagement with the Custom Solutions Group; ensures biopharma customer intelligence from custom engagements feeds back into platform roadmap decisions.
• Ensures broad technical enablement through external scientific publications, white papers, application notes, and conference presentations that establish CST platform leadership and credibility in the translational research market
• Attends relevant industry conferences to gather intelligence and engage with scientists and KOLs.
• Hires and develops scientific expertise within the immunoassay platforms core, with an emphasis on biopharma workflow support; ensures sub-team leaders have the necessary skills required to support pre/post-sales engagement.

Commercial & BD Partnership (25%)

• Operates as the primary R&D interface for the Platform Commercial segment; works in close collaboration and shares accountability with the biopharma commercial team and Product Marketing Managers (PMMs) to align platform development priorities with commercial pipeline and customer needs. Collaborates with Biopharma Marketing, Business Development (BD), and Sales leaders to define business and revenue objectives.
• Partners with Field Application Scientists (FAS) to ensure pre/post-sales technical support capability keeps pace with platform complexity; defines FAS capability requirements and provides scientific direction for FAS training.
• Works tightly with BD in partnership identification, designing deal objectives, and scientific due diligence for platform-adjacent opportunities - spatial, IVD, single-cell, proximity, and proteomics partnerships.
• Engages directly with key pharma accounts and KOLs to understand workflow needs, validate platform positioning, and identify unmet needs that translate into produc